HbA1c

Most people meet this number when a lab report says their sugar is a little high. It answers a bigger question than any finger-stick or fasting draw: how high has your blood sugar actually been running, day and night, for the last three months.

That makes it a useful early signal that you are drifting toward diabetes. It is not the first thing to move. Fasting insulin and HOMA-IR can rise while HbA1c is still ordinary, and an oral glucose tolerance test can catch some cases this test misses. HbA1c's strength is different: it shows sustained glucose exposure.

What HbA1c Actually Measures

HbA1c is measured from a blood sample that includes your red blood cells, usually from a standard blood draw. The lab measures the share of hemoglobin in those cells that has glucose stuck to it. Hemoglobin is the protein inside red blood cells that carries oxygen. The more sugar circulating, the more hemoglobin gets coated, and once glucose attaches it stays there for the life of the cell.

Red blood cells circulate for about 120 days, so the test reads out a running average rather than a single moment. It leans toward recent weeks: roughly half the value reflects the past month, with the earlier two months each contributing progressively less. A large change can start to show within weeks, but the full value catches up slowly.

Type 2 Diabetes and Prediabetes

Because the test is standardized, HbA1c is one of the main lab tests used to screen for and diagnose diabetes and prediabetes, and it needs no fasting. The official diagnostic lines are population lines, not personal targets. Risk rises smoothly rather than switching on at a cutoff.

Its edge is catching sustained high sugar that a single fasting draw skips. When one large Korean survey added HbA1c to fasting glucose, estimated diabetes rose from 10.5 to 12.4 percent, and prediabetes nearly doubled, from 19.3 to 38.3 percent. A fasting number is one snapshot. This is the two-to-three-month story.

The trade-off is sensitivity. At the standard diabetes line the test is specific but blunt: it rarely calls diabetes when it isn't there, but it misses real cases, catching only about half of undiagnosed diabetes compared with an oral glucose tolerance test. So a reassuring HbA1c does not fully clear you when risk is high. Pairing it with fasting glucose, and sometimes an oral glucose tolerance test, gives a sharper answer.

Heart Attacks, Strokes, and Early Death

Higher HbA1c tracks with more heart attacks, strokes, and death, and the climb begins below the diabetes line. In a European study of 36,180 adults, higher levels predicted cardiovascular death and disease even in people without diabetes. A Canadian study of 608,474 adults with no diabetes at the start found higher HbA1c tracked with higher cardiovascular risk before diabetes.

The relationship is not a straight line, though. Pooling 46 studies, both very high and very low HbA1c were tied to higher death rates, with the lowest risk landing around 6.0 to 8.0 percent in people with diabetes and 5.0 to 6.0 percent in people without. That is a population pattern, not a target to chase.

That U-shape is not a reason to want a higher number if you are healthy. Very low readings in these populations often flag something other than good control: serious illness, poor nutrition, a shortened red-cell life, or sugar driven down hard by medication. This is not a lower-is-always-better marker once treatment enters the picture. In ACCORD, an intensive drug strategy aiming for near-normal HbA1c raised deaths in high-risk type 2 diabetes and did not cut the main cardiovascular outcome. If you are tracking your own trend without diabetes, a steady lower-normal value is reassuring; the danger at the bottom of the curve mostly belongs to sick or heavily medicated patients.

Chronic Kidney Disease

In people with both type 2 diabetes and chronic kidney disease, higher levels matter. In the KNOW-CKD cohort, compared with the study's lower HbA1c group, a value of 7.0 to 7.9 percent came with about 60 percent higher risk of a major cardiovascular event or death, and 8 percent or above with roughly double the risk.

Kidney disease is also one of the settings where the number itself gets less trustworthy, because it changes how long red cells survive. When your result and your kidneys are both in question, the test needs backup, which the section below spells out.

Why One Reading Is Not Enough

HbA1c is not a fixed trait, and a single value can sit a surprising distance from your true average. A huge primary-care analysis estimated real-world swing within the same person to be about threefold larger than older lab studies suggested. One reading is a data point, not a verdict.

The swings between visits also carry their own signal. In a trial of people with type 2 diabetes and kidney disease, those with the most visit-to-visit variability had about 50 percent higher risk of major artery events and nearly three times the risk of kidney events than those with the steadiest values. A trajectory tells you far more than any lone result.

Because the number moves slowly, retesting after only a few weeks can be hard to interpret unless the change is large. Get a baseline. If you are making changes, retest at around three months, once the value has had time to catch up to your new pattern. When it is stable, yearly is reasonable if you have prediabetes, diabetes, or meaningful risk factors; every few years may be enough if risk is low.

When a Single Result Can Fool You

The thing to know is simple: anything changing how long red cells live changes this number, regardless of your actual sugar. When a reading clashes with how you feel or with your home glucose checks, one of these is often why.

• Iron and anemia: iron deficiency tends to push the value falsely high, while recent blood loss, a transfusion, pregnancy, or a condition that destroys red cells early tends to pull it falsely low.
• Inherited hemoglobin differences: hemoglobin variants, common in people of African, Mediterranean, and South or Southeast Asian ancestry, can throw the result off sharply depending on the lab method. In a review of rare variants, unacceptable errors ranged from 7 percent of results on one method to 89 percent on another, and the G6PD G202A variant lowered the value by about 0.81 points in men who carry it, enough to leave roughly 2 percent of African American adults with diabetes undiagnosed by this test alone.
• Advanced kidney disease: as kidney function falls, the tie between this number and your real glucose weakens.
• What it can't see: it averages everything out, so it misses short-term spikes and low-sugar episodes entirely.

What to Do With an Out-of-Pattern Result

If your result surprises you, high when you feel fine, or at odds with your home readings, the move is neither to shrug it off nor to panic. First, confirm with a repeat test, since a diabetes-level result on a one-off draw should be verified. Pair it with a fasting glucose, and if the picture stays murky, an oral glucose tolerance test can catch blood sugar problems this number misses.

If the value looks too good given your glucose checks, or you have anemia, a known hemoglobin trait, kidney disease, or are pregnant, check a blood count and iron studies, and consider fructosamine or a continuous glucose monitor, both of which sidestep red-cell effects. A rising trend paired with high fasting insulin or a strong family history is a reason to act early rather than wait to cross a line, and a discordant result alongside odd red-cell results is worth an endocrinologist's read.